{Ifinatamab, | This novel medicinal antibody, | The clinical-stage antibody , is attracting increasing focus owing to its targeted mode of activity. This drug specifically binds to B7-H3, a surface molecule frequently found on multiple cancer entities . Early research findings demonstrate possible effectiveness in treating various range of refracto